subcotan How? ... many doctors do not care about injection techniques
It helps you for support, maybe the site ...
beautifully illustrated explanation
http://www.hepatitis-c-online.de/spritzen_technik_hepatitis-c.php
From
: Www.medizinfo.de / ... / anatomy / injektion.htm
"
of DGKP Gerhard Lesch
out the administration of a sc injection is still controversy over some steps to discussions about the proper execution are often canceled by the remark. "We have discussed it a thousand times" or "We do that here always like that." The authority to examine key aspects to admit nurses to not, and many doctors do not care about injection techniques.
... form
skin fold.
So safe in the subcutaneous adipose tissue (subcutaneous tissue) can be injected, a fold of skin formed. In patients with a very pronounced subcutis can be injected without wrinkles, if it is certain that the needle comes to rest in the subcutaneous tissue.
...
What is this angle depends on the length of needles and the expression of adipose tissue. In normal weight patients, with up to 15 mm long needle at right angle to the skin surface is to be pierced. For longer needles or very thin patients, the angle is to reduce to 45 degrees.
...
aspirate (suck or something)
about whether to be aspirated after insertion, is arguing for a long time.
... The argument that, with the aspiration of tissue aspirated and thus the injection site being damaged in a particular way can not be accepted.
... It may be objected here that in properly conducted aspiration large movements are not necessary.
... A blood vessel into which one can penetrate with the needle tip in whole or in part, is large enough that can arise from improper handling a faulty injection. The patient, it "caught", it will not be comforted that it only occurs very rarely.
...
inject slowly. If the needle is placed
sure that the medicine is injected slowly. By the same long-Injection - Depending on the amount of about 10 to 20 seconds - can spread the good medicinal products between the adipose tissue.
...
remove needle quickly.
...
only when running after the puncture fluid or blood, should be nachgetupft gently with a swab. Do not rub or massage
!
...
drugs are injected subcutaneously, if the agent is to be slowly absorbed and metabolized. The massage and thus be-necessarily improve circulation, however, the drug received and processed quickly.
"
From http://www.krankenschwester.de/forum/pflegebereich-innere-medizin/3701-frage-subkutanen-injektionen.html
"
so we have time so learned that at the sc injection, not aspiration! Why should they?
syringes ... I do not ... aspirated
you have to be always clear that you are subcutaneous and not intrvenös! So I'm sure I aspire, nor is any dead tuned!
... I have learned (5 years ago) and pass on this, that I must not aspire Feritgspritzen (also so described by the manufacturer) Other sc injections are made with skin fold and aspirated ... Greetings from Switzerland ...
Source: Care Today, 2nd edition 2001 page 378-379
The question whether to be aspirated prior to sc injection, can be not always answer. While distance from the injection of heparin due to the possible formation of hematoma aspiration is to be taken must be observed during the injection of other drugs such as analgesics, information from the manufacturers.
...
injection sites:
all body regions with distinct subcutaneous (fat) tissue are suitable for subcutaneous injection.
are preferred:
- The abdominal wall left and right, and below and above the belly button
- The lateral and anterior surfaces of both thighs
- The lateral surfaces of both upper arms
...
should always inject half-moon shape under the navel.
In the area there is a blood-vessel-poor area of the skin, especially low in larger vessels, which you might otherwise infringe upon insertion. In addition, the subcutaneous tissue including quite thick, about 1.5 cm and more ...
...
meantime, however, say the textbooks needed something else ...... NO more aspiration.
...
Be ye always sure that your injected subcutaneously and not "accidentally" have taken a small venous capillaries and thus injected iv?
...
SURE I'm not, that's probably true ...
When insulin is not so aspirated .....
...
I know it so that one aspiration, especially for insulin. It is, after all, not a premature onset be achieved by accidental venous application. No aspiration only with heparin, because people tend to causes damage by aspiration.
...
nochwas And, I have the nursing degree before me today are (page 316, about sc-Inj.) And the plot line for the implementation is explicitly 'non-aspirate' ...
...
I have just looked in our Pflegstandarts thick and there is written, "not aspirate!
...
After it actually happened to me 3 times that I've accidentally set a bolus into the vein and then had serious side effects, I now aspirate very carefully. Bottom Line: I would recommend, very easy to aspirate before injecting. But I think everyone should stick to the specifications will convince him.
...
So I took exams in October 2005 and we have learned to aspirate more!
...
For sc injections, it is quite impossible to take a vein, as is injected into the subcutaneous fat tissue, ie. here must not be aspirated.
... Since
must disagree, I am afraid. It may well be a vein to take the drug and therefore not just be injected into the subcutaneous fatty tissue.
"
http://images.google.com/ ..
"
Normally, only small amount is injected subcutaneously. Frequently, the area of the thigh or abdomen is chosen because given that the "skin is especially thick.
"
Wednesday, July 29, 2009
Thursday, July 23, 2009
Synyster Gates Hairstyle How To
recommendations for daily intake of polyunsaturated fatty acids
From
http://www.vis.bayern.de/ernaehrung/ernaehrung/ernaehrung_krankheit/rheuma.htm # flammable
Table 3: Recommendations for daily intake of polyunsaturated Fettsäuren1) in inflammatory rheumatic diseases
fatty acid daily recommended intake
Omega-6 fatty acids arachidonic acid do not exceed 80 mg linoleic acid
not more than 8 g
Omega-3 fatty acids eicosapentaenoic acid 0.3 g 2)
?-linolenic
4 g 1) Source : modified after Adam, 2004
2 g) daily at the start of treatment 0.9
From
http://www.vis.bayern.de/ernaehrung/ernaehrung/ernaehrung_krankheit/rheuma.htm # flammable
Table 3: Recommendations for daily intake of polyunsaturated Fettsäuren1) in inflammatory rheumatic diseases
fatty acid daily recommended intake
Omega-6 fatty acids arachidonic acid do not exceed 80 mg linoleic acid
not more than 8 g
Omega-3 fatty acids eicosapentaenoic acid 0.3 g 2)
?-linolenic
4 g 1) Source : modified after Adam, 2004
2 g) daily at the start of treatment 0.9
Sunday, July 19, 2009
Mount And Blade Perfect Stats
Copaxone: Not able to sleep
http://www.ms-gateway.de/forum/topic/multiple-sklerose-flush-und-copaxone-27668.htm?pindex=2&t=27668
Betaferon I always injected immediately before bedtime, the went very well.
But now I was able to move and injected earlier, because twice I fall asleep why not, so this was extreme!
Who knows of the Copaxone users it?
It greets you
LadyStardust.
I also know that if I inject too late that I can not sleep. Then I always totally turned me in bed and roll back and forth. disappeared
Andrea
after 2 -3 months, almost all Yes side effects un dheute? I have not even one more is to see the injection site, there is no redness nothing there!
PS what do you should not: Before spraying and after spraying with a cold pack cool from the freezer. Please, only one on the refrigerator.
http://www.ms-gateway.de/forum/topic/multiple-sklerose-flush-und-copaxone-27668.htm?pindex=2&t=27668
Betaferon I always injected immediately before bedtime, the went very well.
But now I was able to move and injected earlier, because twice I fall asleep why not, so this was extreme!
Who knows of the Copaxone users it?
It greets you
LadyStardust.
I also know that if I inject too late that I can not sleep. Then I always totally turned me in bed and roll back and forth. disappeared
Andrea
after 2 -3 months, almost all Yes side effects un dheute? I have not even one more is to see the injection site, there is no redness nothing there!
PS what do you should not: Before spraying and after spraying with a cold pack cool from the freezer. Please, only one on the refrigerator.
Do You Need A Dongle For Drums And Guitar
Copaxonex - Extract from 2005 - 1356 pages therapy Neurology Encyclopedia By Peter Berlit:
Extract from 2005 - 1356 pages
therapy Neurology Encyclopedia By Peter Berlit:
Common finished product:
Copaxonex 20 mg. Powder and injection means for injection solution. Each contains 20 mg
Durchstechtlasche glatiramer acetate, equivalent to 18 mg glatiramer.
Mwendtmgsgebiete
Copaxonex is indicated for the reduction of the shear rate in ambulatory patients (ie
those that are able to walk unaided) with relapsing-remitting multiple sclerosis (MS). hei which at least two attacks of neurological dysfunction during the last 2 years have occurred.
Copaxone "is not indicated for primary or secondary progressive MS.
Under the long-term treatment were in the sera of patients found antibodies against glatiramer acetate. These reached after an average treatment period of 3-4 months maximum concentration and increased thereafter up to a concentration as the off-the gcringfiigig was higher than the initial concentration. There is no evidence up there, that the antibodies against glatiramer acetate contribute neuralisierend or affect the clinical efficacy of Copaxone "can.
In all clinical trials most often reactions observed at the injection site and the majority of patients Copaxone were` reported. In controlled trials, the number of patients, these reactions at least once reported in the group treated with Copaxonc. higher than in the group taking placebo, he held (82% vs. verum. 48% placebo). The most common of these local reactions include erythema, pain, hives, pruritus, edema, inflammation, or increased tenderness at the injection site.
immediate post-injection reactions were related with at least one of the following symptoms overwritten: vasodilation, chest pain, dyspnea, palpitations or tachycardia. These reactions may, within minutes after an injection of Copaxone occur. At least one symptom of the immediate Postinjcktions reactions was during the treatment period at least once by 41% of patients treated with Copaxone, were compared with 20% of patients on placebo, reported
adverse effects.
Within minutes injection of Copaxone may "reactions occur with at least one of the following symptoms: vasodilation (flushing). Chest pain, shortness of breath. Palpitations or tachycardia. The patient must be informed by the treating physician about the possible occurrence of such reactions. Most of these reactions are short lived and resolve spontaneously without any further consequences. In rare cases it can cause severe hypersensitivity reactions (eg Bonchospasmus, anaphylaxis or urticaria) can occur.
There is no evidence that respect for certain groups of patients these reactions ncn a particular risk. Nevertheless, caution is advised when Copaxonek is administered to patients with pre-existing heart disease. These patients should be monitored regularly during treatment.
Under the long-term treatment were in the sera of patients antibodies found against glatiramer acetate. These reached after an average treatment period of 3-4 months maximum concentration and increased thereafter up to a concentration of like-from. which was slightly higher than the initial concentration. There is no evidence up there, that the antibodies against glatiramer acetate neuralisierend affect or influence the clinical efficacy of Copaxonek can.
In all clinical trials at the most common reactions observed at the injection site and the majority of patients Copaxonc received "reports. In controlled trials, the number of patients who reported these reactions at least once in the group. Treated with Copaxonek were higher than in the group, the placebo-he kept 012% vs. verum. 48% placebo). The most common of these local reactions include erythema, pain. Hives. Pruritus, edema, inflammation, or increased tenderness at the injection site.
Immediate post-injection reactions were herschrieben in connection with at least one of the following: vasodilation, chest pain, dyspnea, palpitations or tachycardia. These reactions may, within minutes after an injection of Copaxonc occur '. At least one symptom of the immediate post-injection reactions during the treatment period was at least once by 41% of patients treated with Copaxone ", to 20% of patients receiving placebo reported.
In the following Table 1 lists all adverse events that occurred more frequently in patients treated with Copaxonc 'than in placebo-treated patients.
Extract from 2005 - 1356 pages
therapy Neurology Encyclopedia By Peter Berlit:
Common finished product:
Copaxonex 20 mg. Powder and injection means for injection solution. Each contains 20 mg
Durchstechtlasche glatiramer acetate, equivalent to 18 mg glatiramer.
Mwendtmgsgebiete
Copaxonex is indicated for the reduction of the shear rate in ambulatory patients (ie
those that are able to walk unaided) with relapsing-remitting multiple sclerosis (MS). hei which at least two attacks of neurological dysfunction during the last 2 years have occurred.
Copaxone "is not indicated for primary or secondary progressive MS.
Under the long-term treatment were in the sera of patients found antibodies against glatiramer acetate. These reached after an average treatment period of 3-4 months maximum concentration and increased thereafter up to a concentration as the off-the gcringfiigig was higher than the initial concentration. There is no evidence up there, that the antibodies against glatiramer acetate contribute neuralisierend or affect the clinical efficacy of Copaxone "can.
In all clinical trials most often reactions observed at the injection site and the majority of patients Copaxone were` reported. In controlled trials, the number of patients, these reactions at least once reported in the group treated with Copaxonc. higher than in the group taking placebo, he held (82% vs. verum. 48% placebo). The most common of these local reactions include erythema, pain, hives, pruritus, edema, inflammation, or increased tenderness at the injection site.
immediate post-injection reactions were related with at least one of the following symptoms overwritten: vasodilation, chest pain, dyspnea, palpitations or tachycardia. These reactions may, within minutes after an injection of Copaxone occur. At least one symptom of the immediate Postinjcktions reactions was during the treatment period at least once by 41% of patients treated with Copaxone, were compared with 20% of patients on placebo, reported
adverse effects.
Within minutes injection of Copaxone may "reactions occur with at least one of the following symptoms: vasodilation (flushing). Chest pain, shortness of breath. Palpitations or tachycardia. The patient must be informed by the treating physician about the possible occurrence of such reactions. Most of these reactions are short lived and resolve spontaneously without any further consequences. In rare cases it can cause severe hypersensitivity reactions (eg Bonchospasmus, anaphylaxis or urticaria) can occur.
There is no evidence that respect for certain groups of patients these reactions ncn a particular risk. Nevertheless, caution is advised when Copaxonek is administered to patients with pre-existing heart disease. These patients should be monitored regularly during treatment.
Under the long-term treatment were in the sera of patients antibodies found against glatiramer acetate. These reached after an average treatment period of 3-4 months maximum concentration and increased thereafter up to a concentration of like-from. which was slightly higher than the initial concentration. There is no evidence up there, that the antibodies against glatiramer acetate neuralisierend affect or influence the clinical efficacy of Copaxonek can.
In all clinical trials at the most common reactions observed at the injection site and the majority of patients Copaxonc received "reports. In controlled trials, the number of patients who reported these reactions at least once in the group. Treated with Copaxonek were higher than in the group, the placebo-he kept 012% vs. verum. 48% placebo). The most common of these local reactions include erythema, pain. Hives. Pruritus, edema, inflammation, or increased tenderness at the injection site.
Immediate post-injection reactions were herschrieben in connection with at least one of the following: vasodilation, chest pain, dyspnea, palpitations or tachycardia. These reactions may, within minutes after an injection of Copaxonc occur '. At least one symptom of the immediate post-injection reactions during the treatment period was at least once by 41% of patients treated with Copaxone ", to 20% of patients receiving placebo reported.
In the following Table 1 lists all adverse events that occurred more frequently in patients treated with Copaxonc 'than in placebo-treated patients.
Tuesday, July 14, 2009
Brent Corrigan Free Ipod
which treatment center, rehabilitation?
rehabilitation before pension.
In the ninth book of the Social Code (SGB IX), the term "vocational rehabilitation" by the term "benefits for participation in working life" shall be replaced. Such services must be approved in principle, if a retirement prevented and permanent reintegration can be achieved to work. Since 1 April 2007 are also all the benefits of medical rehabilitation services of statutory duty Health insurance.
The legislature assumes that every patient, he would not have to provide in a rehabilitation clinic, certain expenses incurred for their daily living. To such expenditure so the patient if the insurance company to pay the rehabilitation costs in the form of a supplement of 10 € per day of hospital stay involved. Co-payments need only to achieve the breaking point (1% of gross revenue.) ... be made.
These people are under the following conditions at the request completely or partially exempt from the surcharge, in case of doubt the respective cost carrier will however remain on individual exemption possibilities.
net monthly income: to € 980.00: no charge ... Welfare recipients can be exempted on request, also complete the payment.
http://www.curado.de/Multiple-Sklerose/Rehabilitation-Das-sollten-Patienten-wissen-4910/
Prof. Dr. Thomas Henze: If you brought the last rehab every success, you should definitely try again to get a permit. The decisive factor is always that the relevant request reasonable grounds (and targets) for a new rehab contains. Also important is whether these goals (approved would then possibly an outpatient rehab) on an outpatient way or only in the stationary frame are available. Perhaps you, your neurologist support the application, too. Chance does a new application then sure.
13:01:04
clinics:
http://ms.rehawelt.de/index.php?id=885
www.degemed.de
http://www.medfuehrer.de/445, 8.0, de , 3.4 / Arzt-und-Kliniksuche/Neurologie-Neurologen.html
Multiple Sclerosis - MS Therapy Centre - Centre for Multiple ...
alternate MS therapies, complex nutritional and metabolic therapy for dr. olaf Hebener, targeted therapy: disease stopped Seviton, private clinic.
www.ms-therapiezentrum.de/
http://www.websitewiki.de/Ms-therapiezentrum.de # Verwandte_Websites
Neurological Rehabilitation Center 75323 Bad Wildbad Quellenhof Baden-Württemberg
http://www.quellenhof.de/multiple-sklerose/remus-konzept.php
lecture topics * diagnosis, disease course and prognosis of MS * Immunomodulatory treatment of MS * MS * Symptomatic treatment of stress and MS, Stressbe- coping and psychological immune system * * * Health-conscious behavior of physiotherapy in MS * Social aspects, severely handicapped, and Labor * Dealing with incontinence.
funny is going on then nothing. it seems to admit differences in treatment centers.
Sauerland Clinic 59846 Sundern-Hache Hache North Rhine-Westphalia
Clinic of Neurology Dietenbronn GmbH, Academic Hospital of the University of Ulm 88 477 Schwendi Baden-Württemberg
Neurology Selzer offers GmbH & Co. KG 72270 Baiersbronn-Schönmünzach Baden-Württemberg
Augusta Hospital Anholt 46419 Isselburg-Anholt, Nordrhein-Westfalen
rehab center Nittenau
The clinic in addition to drug therapy in MS an extensive physical and occupational therapy and speech therapy and neuropsychology at. In addition, there are a massage parlor, a large movement and exercise therapy, a dietitian and a social service.
Clinic of Neurology Dietenbronn GmbH, Academic Hospital of the University of Ulm.
... This is achieved by making the eating habits to be reconciled with the disease. Patients is a healthy, wholesome food are served according to the guidelines of the German Society for Multiple Sclerosis. All popular diets such as Low cholesterol diet, diabetes food, light food / stomach diet, low purine diet, reducing diet, vegetarian food and a balanced diet for allergies or food intolerance.
Augusta Hospital Anholt Address: Augustastr. 8 46419 Isselburg Anholt-Rhine-Westphalia, Germany. recognized for 25 years as a Neurological Department, Division of Multiple Sclerosis
Our hospital is known for its good food and his selection of food.
http://ms.rehawelt.de/index.php?id=1159&klinikid=1765
rehabilitation before pension.
In the ninth book of the Social Code (SGB IX), the term "vocational rehabilitation" by the term "benefits for participation in working life" shall be replaced. Such services must be approved in principle, if a retirement prevented and permanent reintegration can be achieved to work. Since 1 April 2007 are also all the benefits of medical rehabilitation services of statutory duty Health insurance.
The legislature assumes that every patient, he would not have to provide in a rehabilitation clinic, certain expenses incurred for their daily living. To such expenditure so the patient if the insurance company to pay the rehabilitation costs in the form of a supplement of 10 € per day of hospital stay involved. Co-payments need only to achieve the breaking point (1% of gross revenue.) ... be made.
These people are under the following conditions at the request completely or partially exempt from the surcharge, in case of doubt the respective cost carrier will however remain on individual exemption possibilities.
net monthly income: to € 980.00: no charge ... Welfare recipients can be exempted on request, also complete the payment.
http://www.curado.de/Multiple-Sklerose/Rehabilitation-Das-sollten-Patienten-wissen-4910/
Prof. Dr. Thomas Henze: If you brought the last rehab every success, you should definitely try again to get a permit. The decisive factor is always that the relevant request reasonable grounds (and targets) for a new rehab contains. Also important is whether these goals (approved would then possibly an outpatient rehab) on an outpatient way or only in the stationary frame are available. Perhaps you, your neurologist support the application, too. Chance does a new application then sure.
13:01:04
clinics:
http://ms.rehawelt.de/index.php?id=885
www.degemed.de
http://www.medfuehrer.de/445, 8.0, de , 3.4 / Arzt-und-Kliniksuche/Neurologie-Neurologen.html
Multiple Sclerosis - MS Therapy Centre - Centre for Multiple ...
alternate MS therapies, complex nutritional and metabolic therapy for dr. olaf Hebener, targeted therapy: disease stopped Seviton, private clinic.
www.ms-therapiezentrum.de/
http://www.websitewiki.de/Ms-therapiezentrum.de # Verwandte_Websites
Neurological Rehabilitation Center 75323 Bad Wildbad Quellenhof Baden-Württemberg
http://www.quellenhof.de/multiple-sklerose/remus-konzept.php
lecture topics * diagnosis, disease course and prognosis of MS * Immunomodulatory treatment of MS * MS * Symptomatic treatment of stress and MS, Stressbe- coping and psychological immune system * * * Health-conscious behavior of physiotherapy in MS * Social aspects, severely handicapped, and Labor * Dealing with incontinence.
funny is going on then nothing. it seems to admit differences in treatment centers.
Sauerland Clinic 59846 Sundern-Hache Hache North Rhine-Westphalia
Clinic of Neurology Dietenbronn GmbH, Academic Hospital of the University of Ulm 88 477 Schwendi Baden-Württemberg
Neurology Selzer offers GmbH & Co. KG 72270 Baiersbronn-Schönmünzach Baden-Württemberg
Augusta Hospital Anholt 46419 Isselburg-Anholt, Nordrhein-Westfalen
rehab center Nittenau
The clinic in addition to drug therapy in MS an extensive physical and occupational therapy and speech therapy and neuropsychology at. In addition, there are a massage parlor, a large movement and exercise therapy, a dietitian and a social service.
Clinic of Neurology Dietenbronn GmbH, Academic Hospital of the University of Ulm.
... This is achieved by making the eating habits to be reconciled with the disease. Patients is a healthy, wholesome food are served according to the guidelines of the German Society for Multiple Sclerosis. All popular diets such as Low cholesterol diet, diabetes food, light food / stomach diet, low purine diet, reducing diet, vegetarian food and a balanced diet for allergies or food intolerance.
Augusta Hospital Anholt Address: Augustastr. 8 46419 Isselburg Anholt-Rhine-Westphalia, Germany. recognized for 25 years as a Neurological Department, Division of Multiple Sclerosis
Our hospital is known for its good food and his selection of food.
http://ms.rehawelt.de/index.php?id=1159&klinikid=1765
Sophia Bush Auburn Hair
side effect of Copaxone
The weight gain can also be a side effect of Copaxone (see insert)
The weight gain can also be a side effect of Copaxone (see insert)
Who Do Coaches Talk To On Headsets
plasmapheresis? a possibility?
10/07/2009
plasmapheresis is a significant measure for treatment failures with a MS relapse. This is especially true if previous steroid therapies were not successful. In this respect, the proposal to your doctor's results from this assessment. The overall chances of success of plasmapheresis are pretty good (there are no large studies but extensive experience). The measure we also usually well tolerated. One should not wait with plasmapheresis, if no remission occurred but then promptly initiate further steps.
your Dr. np
MS-life expert: plasmapheresis
of: http://www.curado.de/Multiple-Sklerose/Blutwaesche-Plasmapherese-bei-akuten-MS-Schueben-701/
... In severe symptoms such as severe to profound loss of vision or arm and leg paralysis and if no improvement after corticosteroid should within four to six weeks will be conducted after the start of symptoms, a blood purification (plasmapheresis series).
10/07/2009
plasmapheresis is a significant measure for treatment failures with a MS relapse. This is especially true if previous steroid therapies were not successful. In this respect, the proposal to your doctor's results from this assessment. The overall chances of success of plasmapheresis are pretty good (there are no large studies but extensive experience). The measure we also usually well tolerated. One should not wait with plasmapheresis, if no remission occurred but then promptly initiate further steps.
your Dr. np
MS-life expert: plasmapheresis
of: http://www.curado.de/Multiple-Sklerose/Blutwaesche-Plasmapherese-bei-akuten-MS-Schueben-701/
... In severe symptoms such as severe to profound loss of vision or arm and leg paralysis and if no improvement after corticosteroid should within four to six weeks will be conducted after the start of symptoms, a blood purification (plasmapheresis series).
Subscribe to:
Posts (Atom)